🇺🇸 Platelet Rich Plasma in United States

19 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 19

Most-reported reactions

1. Pain — 4 reports (21.05%)
2. Vomiting — 3 reports (15.79%)
3. Alopecia — 2 reports (10.53%)
4. Constipation — 2 reports (10.53%)
5. Hypertension — 2 reports (10.53%)
6. Weight Increased — 2 reports (10.53%)
7. Autoimmune Disorder — 1 report (5.26%)
8. Autonomic Neuropathy — 1 report (5.26%)
9. Burning Sensation — 1 report (5.26%)
10. Coma — 1 report (5.26%)

Source database →

Frequently asked questions

Is Platelet Rich Plasma approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Platelet Rich Plasma in United States?

Wroclaw Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.